Cargando…
AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling
Cancer stem cells (CSCs) are the core factors leading to recurrence, insensitivity to radiotherapy and chemotherapy, and immunotherapy resistance in patients with colorectal cancer. AT7867, a potent oral AKT inhibitor, was found to have antitumor activity in colorectal cancer; however, the effect on...
Autores principales: | Li, Yuchen, Yuan, Yun, Yang, Luyao, Chen, Hongqing, Zhang, Xufan, Wen, Tian, Liao, Wenhao, Zhao, Maoyuan, Zhao, Ziyi, Hu, Qiongying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943616/ https://www.ncbi.nlm.nih.gov/pubmed/36824410 http://dx.doi.org/10.1155/2023/4199052 |
Ejemplares similares
-
Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m(6)A Methylation
por: Zhao, Ziyi, et al.
Publicado: (2021) -
AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms
por: Zhang, Shihu, et al.
Publicado: (2017) -
Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal
por: Chen, Zhixing, et al.
Publicado: (2022) -
Zymosan-A promotes the regeneration of intestinal stem cells by upregulating ASCL2
por: Du, Jicong, et al.
Publicado: (2022) -
Epigenetic Editing of Ascl1 Gene in Neural Stem Cells by Optogenetics
por: Lo, Chiao-Ling, et al.
Publicado: (2017)